Cairo – Mubasher: Kahira Pharmaceuticals' net profits inched up 0.9% to EGP 41.49 million in the fiscal year 2014/2015, from EGP 41.1 million in the previous year.
The company's gross profit reached EGP 93.89 million in FY14/15, compared with EGP 93.68 million for the preceding year.
The drug firm's financial indicators for the ten-month period ended April 2015, showed a decline in net profits of 10% to EGP 50.25 million.
